Results 151 to 160 of about 607,504 (179)

Prevalence and characterization of human immunodeficiency virus coinfection in patients hospitalized with tuberculosis in a reference hospital in Bogotá [PDF]

Biomedica
Puentes-Ariza GC, Meléndez-Rhenals S, Nocua-Báez LC, Páez-Ardila H.   +3 more
europepmc   +1 more source

[Social security burden due to work-related disability due to kidney failure]. [PDF]

Rev Med Inst Mex Seguro Soc
Torres-Toledano M, Molina-Domínguez T, Bautista-De Anda R, Cortés-Sanabria L, Granados-García V, Cueto-Manzano A.   +5 more
europepmc   +1 more source

[Analysis of the reports of contraceptive service providers in Mexico: between reproductive autonomy and contraceptive coercion]. [PDF]

Cad Saude Publica
Quintero-Veloz X, Vallin J, Suchman L, Holt K.   +3 more
europepmc   +1 more source

Costs and impact of the Malaria Eradication Campaign in Colombia, 1957-1969 [PDF]

Biomedica
Padilla-Rodríguez JC, Olivera MJ.
europepmc   +1 more source

[Prevalence of Helicobacter pylori and Endoscopic and Histopathological Fin-dings in Obese Patients who are Can-didates for Bariatric Surgery]. [PDF]

Acta Gastroenterol Latinoam
Martínez Ramírez RM, Nadales Á, Martínez Ramírez MX, Siles Vásquez A, Mejía Díazgranados MJ.   +4 more
europepmc   +1 more source

[Postoperative result in appendectomy with Pouchet technique versus other surgical techniques]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Flores AJ, Rodríguez-Alfaro SE, Mendoza-Rodríguez R, Méndez-Martínez S, Ayón-Aguilar J, García-Flores MA, Aguilar-Cózatl I.   +6 more
europepmc   +1 more source

In Vitro and In Vivo Effects of Resveratrol on Rat Hepatic CYP1A2. [PDF]

Pharmaceuticals (Basel)
Hernández-Ojeda SL, López-Arellano R, Contreras-Ochoa CO, Hernandez-Patlan D, Camacho-Carranza R, Romo-Mancillas A, Aguilera-Durán G, Hernández-Gallardo CA, Cárdenas-Ávila RI, Govezensky TS, Morales-Hipólito EA, Espinosa-Aguirre JJ.   +11 more
europepmc   +1 more source

In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors. [PDF]

Curr Issues Mol Biol
Muñoz-González F, Correa-Basurto J, Ignacio-Mejia I, Bandala C.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly